Evidence map›Paper›PMID 28353183›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2017

Tetanus in adults: results of the multicenter ID-IRI study.

S Tosun, A Batirel, A I Oluk, F Aksoy, E Puca, F Bénézit, S Ural, S Nayman-Alpat, T Yamazhan, V Koksaldi-Motor and 23 more

Open access · greenAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Tetanus - a lethal and neglected infectious disease.Annals of medicine and surgery (2012) · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Tetanus: A disease not to be forgotten.Revista da Sociedade Brasileira de Medicina Tropical · 2023
    Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 20 institutions in 6 countries.

S TosunDepartment of Infectious Diseases and Clinical Microbiology, Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.
A BatirelDepartment of Infectious Diseases and Clinical Microbiology, Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey.
A I OlukDepartment of Infectious Diseases and Clinical Microbiology, Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.
F AksoyDepartment of Infectious Diseases and Clinical Microbiology, Karadeniz Technical University School of Medicine, Trabzon, Turkey.
E PucaDepartment of Infectious Diseases, University Hospital Center "Mother Teresa", Tirana, Albania.
F BénézitInfectious Diseases and Intensive Care Unit, University Hospital of Pontchaillou, Rennes, France.
S UralAtaturk Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Katip Celebi University, Izmir, Turkey.
S Nayman-AlpatDepartment of Infectious Diseases and Clinical Microbiology, Osmangazi University School of Medicine, Eskisehir, Turkey.
T YamazhanDepartment of Infectious Diseases and Clinical Microbiology, Ege University School of Medicine, Izmir, Turkey.
V Koksaldi-MotorTayfur Ata Sokmen School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Mustafa Kemal University, Hatay, Turkey.
R TekinDepartment of Infectious Diseases and Clinical Microbiology, Dicle University School of Medicine, Diyarbakir, Turkey.
E ParlakDepartment of Infectious Diseases and Clinical Microbiology, Ataturk University School of Medicine, Erzurum, Turkey.
P TattevinInfectious Diseases and Intensive Care Unit, University Hospital of Pontchaillou, Rennes, France.
K Kart-YasarDepartment of Infectious Diseases and Clinical Microbiology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.
R GunerAtaturk Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Yildirim Beyazit University, Ankara, Turkey.
A BastugDepartment of Infectious Diseases and Clinical Microbiology, Numune Training and Research Hospital, Ankara, Turkey.
M Meric-KocDepartment of Infectious Diseases and Clinical Microbiology, Kocaeli University School of Medicine, Izmit, Turkey.
S OncuDepartment of Infectious Diseases and Clinical Microbiology, Adnan Menderes University School of Medicine, Aydin, Turkey.
A Sagmak-TartarDepartment of Infectious Diseases and Clinical Microbiology, Firat University School of Medicine, Elazig, Turkey.
A DenkDepartment of Infectious Diseases and Clinical Microbiology, Firat University School of Medicine, Elazig, Turkey.
F PehlivanogluDepartment of Infectious Diseases and Clinical Microbiology, Haseki Training and Research Hospital, Istanbul, Turkey.
G SengozDepartment of Infectious Diseases and Clinical Microbiology, Haseki Training and Research Hospital, Istanbul, Turkey.
S M SørensenDepartment of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark.
G CelebiSchool of Medicine, Department of Infectious Diseases and Clinical Microbiology, Bulent Ecevit University, Zonguldak, Turkey.
L BaštákováFaculty Hospital Brno, Department of Infectious Diseases and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
H GedikDepartment of Infectious Diseases and Clinical Microbiology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.
S Dirgen-CaylakDepartment of Infectious Diseases and Clinical Microbiology, Mugla Sitki Kocman University School of Medicine, Mugla, Turkey.
A EsmaogluFaculty of Medicine, Department of Anesthesiology Intensive Care Unit, Erciyes University, Kayseri, Turkey.
S ErolDepartment of Infectious Diseases and Clinical Microbiology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
Y CagSchool of Medicine, Department of Infectious Diseases and Clinical Microbiology, Medeniyet University, Istanbul, Turkey.
E KaragozDepartment of Infectious Diseases and Clinical Microbiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.
A InanDepartment of Infectious Diseases and Clinical Microbiology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
H ErdemPrincipal Coordinator of ID-IRI, Ankara, Turkey. hakanerdem1969@yahoo.com.
Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi · TRFırat University · TRHaseki Eğitim ve Araştırma Hastanesi · TRHaydarpaşa Numune Eğitim ve Araştırma Hastanesi · TRHôpital Pontchaillou · FRIzmir Bozyaka Eğitim ve Araştırma Hastanesi · TRAalborg University Hospital · DKAdnan Menderes University · TRAnkara Yıldırım Beyazıt University · TRAtatürk University · TRBülent Ecevit University · TRDicle University · TRDr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi · TREge University · TRErciyes University · TREskişehir Osmangazi University · TRFatih Sultan Mehmet Eğitim Ve Araştırma Hastanesi · TRIstanbul Medeniyet University · TRIzmir Kâtip Çelebi University · TRKaradeniz Technical University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tetanus is an acute, severe infection caused by a neurotoxin secreting bacterium. Various prognostic factors affecting mortality in tetanus patients have been described in the literature. In this study, we aimed to analyze the factors affecting mortality in hospitalized tetanus patients in a large case series. This retrospective multicenter study pooled data of tetanus patients from 25 medical centers. The hospitals participating in this study were the collaborating centers of the Infectious Diseases International Research Initiative (ID-IRI). Only adult patients over the age of 15 years with tetanus were included. The diagnosis of tetanus was made by the clinicians at the participant centers. Izmir Bozyaka Education and Research Hospital's Review Board approved the study. Prognostic factors were analyzed by using the multivariate regression analysis method. In this study, 117 adult patients with tetanus were included. Of these, 79 (67.5%) patients survived and 38 (32.5%) patients died. Most of the deaths were observed in patients >60 years of age (60.5%). Generalized type of tetanus, presence of pain at the wound area, presence of generalized spasms, leukocytosis, high alanine aminotransferase (ALT) and C-reactive protein (CRP) values on admission, and the use of equine immunoglobulins in the treatment were found to be statistically associated with mortality (p < 0.05 for all). Here, we describe the prognostic factors for mortality in tetanus. Immunization seems to be the most critical point, considering the advanced age of our patients. A combination of laboratory and clinical parameters indicates mortality. Moreover, human immunoglobulins should be preferred over equine sera to increase survival.

Indexed as

AdolescentAdultAgedAged, 80 and overAnimalsFemaleHospitalizationHumansMaleMiddle AgedPrognosisRetrospective StudiesRisk AssessmentSurvival AnalysisTetanusYoung Adult

Identifiers

PMID28353183
OpenAlexW2600452455

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.